![]() |
| Image Source: "Zhejiang Angelalign Medical Technology Co., Ltd. Initial Public Offering and Listing Tutoring Filing Report" |
DentalGoodNews|Zhejiang Angelalign Medical Technology Co., Ltd. (hereinafter referred to as "Angelalign") signed a tutoring agreement with China Securities Co., Ltd. on February 6, 2026, and completed the filing for its initial public offering (IPO) and listing tutoring with the Zhejiang Regulatory Bureau of the China Securities Regulatory Commission (CSRC). This marks the company's second attempt to initiate the A-share listing tutoring process.
Angelalign was founded in December 2010 with a registered capital of 360 million yuan. Its production base is located in Jiaxing, Zhejiang, and its main business is Clear Aligner products. It is the third-largest brand in the domestic Clear Aligner Therapy market and has served approximately 1.5 million patients.
The tutoring institution for this round is China Securities Co., Ltd., the law firm is AllBright Law Offices, and the accounting firm is RSM China. The tutoring plan is divided into three stages: from February to March 2026, a preliminary investigation will be completed; from March to April 2026, intensive training will be conducted, covering regulations such as the "Company Law" and "Securities Law"; from May to June 2026, the preparation of application documents will be completed, and a summary report of the tutoring work will be submitted to the Zhejiang Securities Regulatory Bureau.
The company's controlling shareholder and actual controller, Yao Junfeng, directly holds 20.91% of the company's equity and indirectly holds shares through multiple enterprises such as Nuodun Medical, resulting in a total shareholding of 39.57%. According to the National Enterprise Credit Information Publicity System, prior to the tutoring filing, the company's board of directors underwent personnel adjustments, with Chen Jie and Wu Yinghui stepping down and Loh Kok Kien and Zhu Tianji newly appointed.
![]() |
| Image Source: National Enterprise Credit Information Publicity System |
According to public information, Angelalign first initiated its A-share listing tutoring in May 2023, with China International Capital Corporation Limited and Guohai Securities serving as the sponsoring institutions. That round of tutoring was terminated after the eighth tutoring work report. The current filing documents indicate that the company has not experienced any termination of review, disapproval, or non-registration of its IPO application in the past three years. Additionally, according to a previous report by DGN, on March 20, 2022, Angelalign announced the completion of a 500 million yuan Series D financing round, led by Beijing Taikang Investment.
| About DGN:DentalGoodNews (DGN) is a trusted professional media platform dedicated to the global dental industry. We deliver in-depth coverage of corporate news, policy & regulation, investment & funding, and clinical frontiers — serving dental institutions, device manufacturers, investors, and industry researchers worldwide. Contact us: haodeya@dongxizixun.com |